Primary Radiotherapy of the "intermediate risk" - Prostate Cancer: Comparison between Seeds Brachytherapy and external Radiation therapy (70 or 74 Gy) in 890 Patients

被引:0
|
作者
Goldner, G. [1 ]
Poetter, R. [1 ]
Battermann, J. [2 ]
Schmid, M. P. [1 ]
Sljivic, S. [1 ]
Kirisits, C. [1 ]
van Vulpen, M. [2 ]
机构
[1] Med Univ Wien, Ctr Comprehens Canc, Klin Strahlentherapie & Onkol, Vienna, Austria
[2] Med Univ Utrecht, Dept Radiotherapy & Oncol, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [31] A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
    Slevin, Finbar
    Rodda, Sree Lakshmi
    Bownes, Peter
    Murray, Louise
    Bottomley, David
    Wilkinson, Clare
    Adiotomre, Ese
    Al-Qaisieh, Bashar
    Dugdale, Emma
    Hulson, Oliver
    Mason, Joshua
    Smith, Jonathan
    Henry, Ann M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 20 : 1 - 8
  • [32] A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
    Ciezki, J
    Klein, E
    Angermeier, K
    Ulchaker, J
    Mahadevan, A
    Reddy, C
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S21 - S21
  • [33] A Comparison of Cause-specific Mortality among Patients with Low or Intermediate-risk Prostate Cancer Treated with Brachytherapy, External Beam Radiotherapy or Radical Prostatectomy
    Ciezki, J. P.
    Reddy, C. A.
    Robinson, C.
    Angermeier, K.
    Ulchaker, J.
    Chehade, N.
    Altman, A.
    Klein, E. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S320 - S320
  • [34] Brachytherapy versus external-beam radiation therapy in patients with surgically staged, intermediate-risk endometrial cancer
    Amneus, M.
    Delic, L.
    Cass, I.
    Li, A. J.
    Leuchter, R.
    Karlan, B. Y.
    Walsh, C.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S68 - S69
  • [35] Comparison of LDR Brachytherapy Versus External Beam Radiation Therapy for Low- And Intermediate-Risk Prostate Cancer: A Propensity-Score Matched Analysis
    Rodrigues, G.
    Smith, G.
    Crook, J. M.
    Martin, A.
    Vigneault, E.
    Souhami, L.
    Morris, J.
    Catton, C.
    Lukka, H.
    Warner, A.
    Yang, Y.
    Pickles, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S414 - S415
  • [36] Brachytherapy plus external beam radiation. Long-term results in intermediate to high risk prostate cancer patients
    Ragde, H
    Elgamel, AA
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 366 - 366
  • [37] Impact of Hormonal Therapy on Intermediate Risk Prostate Cancer Treated With Combination Brachytherapy and External Beam Irradiation
    Stock, Richard G.
    Yamalachi, Swati
    Hall, Simon J.
    Stone, Nelson N.
    JOURNAL OF UROLOGY, 2010, 183 (02): : 546 - 550
  • [38] Relapse-free survival with escalating external beam radiation doses in the treatment of localized prostate cancer: 74 Gy at 2 Gy, 78 Gy at 2 Gy, and hypofractionated 70 Gy at 2.5 Gy per fraction
    Mackley, H. B.
    Reddy, C. A.
    Reuther, A. M.
    Mahadevan, A.
    Kupelian, P. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S331 - S331
  • [39] TREATMENT RESULTS OF PDR BRACHYTHERAPY COMBINED WITH EXTERNAL BEAM RADIOTHERAPY IN 106 PATIENTS WITH INTERMEDIATE- TO HIGH-RISK PROSTATE CANCER
    Pieters, Bradley R.
    Geijsen, Elisabeth D.
    Koedooder, Kees
    Blank, Leo E. C. M.
    Rezaie, Elisa
    van der Grient, Johan N. B.
    de Reijke, Theo M.
    Koning, Caro C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1037 - 1042
  • [40] Brachytherapy Alone (BT) Without Supplemental External Beam Radiation Therapy (EBRT) May be Sufficient in Management of Intermediate Risk Prostate Cancer
    Shah, Amit
    Bell, Ted
    Fortier, Gregory
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 210 - 210